It has also been shown that as AD develops, there is an associated increase in the enzyme tyrosine hydroxylase, which is responsible for the rate‐limiting step of norepinephrine synthesis, along with a decrease in the levels of norepinephrine transporter (NET).180, 189. This evidence concerns the gene SLC6A2 and Alzheimer disease.